Scienmag

SEPTEMBER 7, 2020

Researchers have developed a statistical model that uses genomic data to predict the risk of developing cancer of the oesophagus Credit: Spence Phillips / EMBL-EBI Oesophageal cancer is the eighth most common cancer worldwide. It often develops from a condition called Barrett’s oesophagus.

Genomics 52

Genomics Genome Development Research 52

Roots Analysis

AUGUST 28, 2022

The up-and-coming field of spatial genomics in biology promises to bridge the gap between high plex, high throughput, and high resolution. 70+ spatial Genomics solutions are developed by industry and non-industry players. 70+ spatial Genomics solutions are developed by industry and non-industry players.

Genomics 52

Genomics Genome RNA Genome Project 52

pharmaphorum

MARCH 19, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . on Big data: astronomical or genomical? , According to an article by Stephens, Zachary D.,

Bioinformatics 59

Bioinformatics Drugs Genomics Genome 59

Scienmag

JANUARY 13, 2021

To discover these associations, researchers need to compare the genomes of many individuals at millions of genetic locations or markers, and therefore require cost-effective genotyping technologies. A new statistical method, developed […].

Genomics 57

Genomics Genome Genotype Genetics 57

Scienmag

MAY 27, 2021

Credit: LIU Yang Researchers from the Single-Cell Center at the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of the Chinese Academy of Sciences have developed a technique to sort and sequence the genome of bacteria in soil one bacterial cell at a time, while also identifying what its function is in the soil environment. […]. (..)

Bacteria 67

Bacteria Development Research Genomics 67

XTalks

JULY 19, 2021

Phosphorus, a leading preventative genomics company, has developed the first comprehensive preventative genetic test for consumers. Like other consumer genomic tests, the Phosphorus GeneCompass test also involves the collection of saliva samples that consumers send to the Phosphorus lab located in Secaucus, NJ for analysis.

Genetics 98

Genetics Genome Genomics Gene 98

Scienmag

JUNE 14, 2021

HOUSTON – (June 14, 2021) – In the two decades since the Human Genome Project mapped the entire human genome, improvements in technology have helped in developing updated reference genomes used for sequencing.

Genomics 40

Genomics Genome Genome Project Gene 40

Scienmag

SEPTEMBER 22, 2020

Credit: Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai Bottom Line: Given the toll that the COVID-19 pandemic has taken on people’s health and lives worldwide, it is crucial to be able to accurately predict patients’ outcomes, including their chances of mortality from the disease.

Genomics 52

Genomics Genome Development Research 52

pharmaphorum

OCTOBER 20, 2021

A software platform developed by Altoida that uses augmented reality and artificial intelligence to diagnose neurological diseases in their earliest stages is being tested in a five-year trial involving thousands of patients.

Trials 78

Trials Genome Genomics Bioinformatics 78

Scienmag

AUGUST 11, 2020

Researchers from Skoltech, Lomonosov Moscow State University, and the Kharkevich Institute for Information Transmission Problems have studied the genomes of some 200 strains of bacteria to determine which proteins in the ribosome, part of the key cell machinery, can be safely lost and why.

Bacteria 41

Bacteria Genomics Genome Protein 41

pharmaphorum

JANUARY 19, 2022

Developments in the sector have already led to significant scientific breakthroughs. All clients of Single Cell Discoveries will be able to access its platform, BBrowser, which holds single-cell multi-omics analysis developed by BioTuring. The latter was essential to be able to analyse single-cell sequencing.

RNA 72

RNA Research Life Science Bioinformatics 72

The Pharma Data

MARCH 20, 2021

The Kluyver Center for Genomics of Industrial Fermentation in Delft, Holland, is a consortium of several different Universities and Research Centres. Microbial genomics. The Kluyver Center applies microbial genomics to improve the performance of microorganisms in industrial fermentation processes.

Genome 52

Genome Genomics Bioinformatics Production 52

pharmaphorum

MARCH 28, 2022

Via its third call for applications, AION and BioMed X aims to entice innovative thinkers to find ways to develop solutions to common pharma challenges by analysing existing antibody therapies to make new efficient and effective therapies using AI. Then, a development stage or optimisation stage occurs. About the author .

Pharma Companies 98

Pharma Companies Antibody Protein Development 98

XTalks

MAY 20, 2022

A clinical scientist conducts research to help prevent illness and develops techniques to support patient diagnosis and treatment. They also assist in the testing of medical devices and development of drug products. To start applying to clinical scientist jobs today, head over to the Xtalks Job Search platform. Radiotherapy Physics.

Scientist 105

Scientist Life Science Clinical Research Doctor 105

The Pharma Data

SEPTEMBER 11, 2021

“Boehringer Ingelheim believes Twist’s ability to generate potent, diverse therapeutic antibodies by mining its comprehensive libraries, combined with our extensive capabilities and experience in drug discovery and development, will enable us to deliver breakthrough opportunities to patients,” said Clive R. Wood, Ph.D., Leproust, Ph.D.,

Antibody 52

Antibody DNA Containment Manufacturing 52

The Pharma Data

DECEMBER 16, 2020

Evotec and Bristol Myers Squibb (the successor in interest to Celgene ) initiated their long-term strategic drug discovery and development partnership in the field of targeted protein degradation in 2018 with the goal to identify novel drug targets.

Protein 40

Protein Bioinformatics Containment Drugs 40

Worldwide Clinical Trials

APRIL 7, 2025

This variability complicates eligible participant identification and the development of effective treatments, as traditional recruitment methods often result in slow enrollment and high screen-fail rates. Centralization establishes a uniform sample evaluation, reducing inter-site variability and improving data consistency.

Medicine 100

Medicine Research Clinical Trials Clinical Trials 100

pharmaphorum

SEPTEMBER 16, 2022

With approximately one third of all current FDA-approved drugs targeting GPCRs, Verily/Sosei Heptares are looking to expedite GPCR research within not only immunology, but also gastroenterology and immuno-oncology as well, and the latest data bodes well for future development of therapeutic options in these areas. What, then, is the solution?

Development 135

Development Research Drugs Clinical Trials 135

XTalks

NOVEMBER 7, 2022

These tumor-derived entities are used to derive genomic and proteomic data. In addition, Dr. Bahassi stressed that the simple enumeration of CTCs will not contribute significantly to the development of improved or more personalized cancer treatments. Detection of Genomic Alterations from cfDNA: Targeted, Non-Personalized Approaches.

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

Roots Analysis

AUGUST 15, 2024

Understanding Molecular Diagnostic Solutions Molecular diagnostic solutions are advanced techniques and tools used to analyze biological markers in the genome and proteome. Next Generation Sequencing (NGS): DNA sequencing provides comprehensive genomic insights identifying mutations and variations in the sequence.

Marketing 40

Marketing Genetics Genome Genomics 40

pharmaphorum

APRIL 7, 2022

During the initial stage of the collaboration, Ares developed a an AI-powered anti-infectives platform using microbiological lab techniques and bioinformatics that can be used to identify effective antimicrobial compounds or combinations against specific pathogens, which Sandoz can use to inform its “portfolio and commercial decisions.”

Bioinformatics 52

Bioinformatics Genetics Genome Genomics 52

XTalks

DECEMBER 13, 2023

In 2023, biotechnology and pharmaceutical companies leverage cutting-edge technology and significant investments in research and development (R&D) to continue pushing the boundaries of innovation in the healthcare sector, transcending the challenges posed by the pandemic.

Genetics 111

Genetics Vaccination Vaccine DNA 111

The Pharma Data

JANUARY 21, 2021

Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to eight FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. million in awards.

Scientist 40

Scientist Engineer Medicine Bioinformatics 40

The Pharma Data

MAY 22, 2023

WHO launches global network to detect and prevent infectious disease threats WHO and partners are launching a global network to help protect people from infectious disease threats through the power of pathogen genomics. COVID-19 highlighted the critical role pathogen genomics plays in responding to pandemic threats.

Genomics 52

Genomics Genome Bioinformatics Bacteria 52

The Pharma Data

MARCH 20, 2021

professor in Functional Cancer Genomics and Applied. Bioinformatics in the Faculty. use and development of proteomic methods to. The MANTIS. liquid handler has also been pivotal. in reducing assay volumes, providing significant cost savings, and again helping to avoid. delays where reagents are in. short supply. therapeutics.

Reagent 52

Reagent RNA Bioinformatics Medicine 52

The Pharma Data

JANUARY 10, 2021

His company is leveraging the novel cellular immunotherapy development platform he invented to develop novel, targeted, allogeneic cell therapies against cancer with NK cells, the body’s immune cells that specialize in recognizing and attacking cancer cells. Can we develop…almost a preventative therapeutic approach?

Vaccination 52

Vaccination Vaccine Regulation Drugs 52

Roots Analysis

JANUARY 27, 2025

Recent protein expression market trends showcase a growing emphasis on cell free protein expression systems, advanced bioinformatics, and the rise of the protein expression market for kits and reagents. Patients are increasingly seeking personalized therapies, stimulating the demand for customizable and scalable protein expression platforms.

Protein 40

Protein Reagent Marketing Gene 40